Buscar resultados de ensayos clínicos

Patrocinado por

Graves Ophthalmopathy - 22 Studies Found

Estado Estudiar
Completed Nombre del estudio: Optic Disc, Macula, and Retinal Nerve Fiber Layer Measurements Obtained by OCT in Thyroid Associated Ophthalmopathy
Condición: Thyroid Associated Ophthalmopathy
Fecha: 2016-04-24
Intervenciones: Device: Optical Coherence Tomography All groups were measured by optical coherence tomography.
Active, not recruiting Nombre del estudio: Teprotumumab Treatment in Patients With Active Thyroid Eye Disease
Condición:
  • Thyroid Associated Ophthalmopathies
  • Thyro
    Fecha: 2013-05-02
    Intervenciones:
    • Drug: teprotumumab 10mg/kg fir
Not yet recruiting Nombre del estudio: The Effect of a New Antioxidant Combination (ASTED) on Moderate to Severe Thyroid Eye Disease
Condición: Thyroid Eye Disease
Fecha: 2015-04-11
Intervenciones:
  • Drug: Methylprednisolone + ASTED

Completed Nombre del estudio: Hyaluronic Acid Gels for Upper Lid Retraction in Active Stage Thyroid Eye Disease
Condición: Thyroid Eye Disease
Fecha: 2012-10-06
Intervenciones:
  • Drug: Hyaluronic Acid Gel injection

Not yet recruiting Nombre del estudio: The Effect of a New Antioxidant Combination (ASTED) on Mild Thyroid Eye Disease (TED)
Condición: Thyroid Eye Disease
Fecha: 2015-03-07
Intervenciones:
  • Drug: ASTED A tablet of ASTED

Completed Nombre del estudio: Celecoxib for Thyroid Eye Disease
Condición: Thyroid Eye Disease
Fecha: 2016-07-20
Intervenciones:
  • Drug: Celecoxib celecoxib 100m
Completed Nombre del estudio: B-cell Depletion Therapy With Rituximab for Thyroid Eye Disease
Condición: Thyroid Eye Disease
Fecha: 2014-12-08
Completed Nombre del estudio: Rituximab Treatment of Graves' Dysthyroid Ophthalmopathy
Condición:
  • Graves' Dysthyroid Ophthalmopathy
  • Thyroid Related Orbitopathy Fecha: 2007-01-17
    Intervenciones: Drug: Rituximab
Completed Nombre del estudio: Twenty-four Hour Intraocular Pressure Patterns in Patients With Uncontrolled Thyroid Eye Disease
Condición: Thyroid Eye Disease
Fecha: 2013-02-21
Intervenciones: Device: SENSIMED Triggerfish Other Name: Contact lens sensor intented to continuously record IOP pattern
Terminated Nombre del estudio: Lanreotide (Somatuline Autogel) in Thyroid-associated Ophthalmopathy Treatment
Condición: Thyroid-Associated Ophthalmopathy
Fecha: 2006-02-07
Intervenciones: Drug: Lanreotide (Autogel formulation). Duration of treatment - 3 injections, 1 every 28 days
<<< Previous | Next >>>